Journal profile · Multiple
Lancet Regional Health-Americas
ISSN 2667-193X · Elsevier · United Kingdom
Lancet Regional Health-Americas: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 9.1 (journal website); fully open access; APC about USD 5,800; median 121 days to acceptance (95 articles, last 24 months); 372 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Lancet Regional Health-Americas is published by Elsevier and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Global Public Health Policies and Epidemiology, SARS-CoV-2 and COVID-19 Research and Vaccine Coverage and Hesitancy, together about 19.9% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Lancet Regional Health – Americas is a new open access journal, part of The Lancet's global initiative to advocate for health-care quality and access in all regions of the world. The journal fosters the advance of clinical practice and health policy in the Americas, with the ultimate goal of improving health outcomes. We aspire to increase the quality of regional and national health research.The journal publishes high-quality original research that advocates change in, or illuminates, clinical practice and health policy in the Americas. We also consider relevant reviews, commentaries, and opinion pieces. The journal invites submissions that are pertaining to regional health topics, including but not limited to infectious diseases, non-communicable diseases, child and adolescent health, maternal and reproductive health, emergency care, health policy and health equity.
From the journal's Aims & Scope
Research area (LetPub): Multiple
Main research topics OpenAlex counts of recent articles; shares are approximate
- Global Public Health Policies and EpidemiologyBusiness, Management and Accounting7.5%
- SARS-CoV-2 and COVID-19 ResearchMedicine6.4%
- Vaccine Coverage and HesitancySocial Sciences6%
- COVID-19 Clinical Research StudiesMedicine5.6%
- Mosquito-borne diseases and controlMedicine5.4%
- COVID-19 epidemiological studiesMathematics5.2%
- Opioid Use Disorder TreatmentMedicine4.7%
- Global Maternal and Child HealthMedicine4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Health Care Sciences & Services | Zone 2 |
| Minor | Public, Environmental & Occupational Health | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Health Care Sciences & Services | Zone 1 |
| Minor | Public, Environmental & Occupational Health | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 9.1Publisher website ·
- CiteScore 2026-06
- 12.9LetPub ·
- CiteScore (publisher)
- 12.9Publisher website ·
- SJR 2026-06
- 2.83LetPub ·
- SNIP 2026-06
- 2.51LetPub ·
- h-index
- 60OpenAlex ·
- i10-index
- 479OpenAlex ·
- 2-year mean citedness
- 4.27OpenAlex ·
- Self-citation rate
- 3.3%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 233LetPub ·
Articles by year OpenAlex count · 1,580 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 280 | 280 | 96 |
| 2025 | 372 | 372 | 1,320 |
| 2024 | 305 | 305 | 2,675 |
| 2023 | 225 | 225 | 3,665 |
| 2022 | 246 | 246 | 6,188 |
| 2021 | 152 | 152 | 5,042 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
121 daysMedian, submission to acceptance · P25–P75 54 days – 162 days
- Acceptance to online
- median 16 days (95 articles)
- Submission to online
- median 137 days
- Sample
- 95 articles with submission and acceptance dates (720 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 13 weeksLetPub ·
- Submission to first decision
- 4 daysPublisher website ·
- First decision after review
- 56 daysPublisher website ·
- Submission to acceptance
- 133 daysPublisher website ·
- Acceptance to publication
- 19 daysPublisher website ·
- Submission to publication (journal-reported)
- about 29 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 5,800 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 4,930 / EUR 4,610 / GBP 3,950 / JPY 611,470 | — | — | |
| LetPub | USD 4,000 | Yes | — | |
| Publisher website | USD 5,800 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open Access
Article Publishing Charge (APC): USD 5,800 (excluding taxes). This journal is taking part in the GPOA program.Review this journal’s open access policy.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2667-193X
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Lancet Regional Health-Americas
What CAS zone is Lancet Regional Health-Americas in?
In the 2025 upgraded edition of the CAS Journal Ranking, Lancet Regional Health-Americas is in Zone 2 of Medicine, and in Zone 2 of the minor category Health Care Sciences & Services / Public, Environmental & Occupational Health. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Lancet Regional Health-Americas?
The journal's website gives an impact factor of 9.1; this is the journal's own figure, as LetPub lists none for it; CiteScore 12.9, h-index 60.
How long does peer review take at Lancet Regional Health-Americas?
Based on the dates recorded on 95 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 121 days (interquartile range 54–162 days); authors report an average review time of about 13 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Lancet Regional Health-Americas?
According to LetPub and DOAJ records, Lancet Regional Health-Americas is indexed in ESCI, Scopus and DOAJ.
Is Lancet Regional Health-Americas open access, and what is the APC?
Lancet Regional Health-Americas is a fully open-access journal. APC about USD 5,800.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .